Istituto Clinico Humanitas Clinical Trials
Sponsors / Istituto Clinico Humanitas
Istituto Clinico Humanitas is listed as the lead sponsor on 240 clinical trials registered with ClinicalTrials.gov. Across the portfolio, 29 are in recruitment, 5 are active non-recruiting, and 105 have reached completion. 10 trials have been terminated or withdrawn. The most common reasons cited for termination include slow or insufficient recruitment. Across the portfolio, planned enrollment totals 560,642 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.
240
Total Trials
29
Recruiting
5
Other Active
105
Completed
10
Terminated / Withdrawn
560,642
Total Enrollment
Termination reasons: Recruitment80% · Other20%
Recent Terminations
- Secondary Malignant Neoplasm of Liver"not sufficient patient recruited"
- Bladder Cancer"few patients enrolled"
- NCT02616887 Stopped Feb 2022Vertebral Metastases"not sufficient patients enrolled"
- Carcinoma, Basal Cell"low recruitment rate"
- Hepatocellular Carcinoma"too slow enrollment"
- Cancer of Breast"number of enrollments not reached in the estimated time"
- Infertility"Difficulty with patient enrollment"
- NCT02049424 Stopped Nov 2013Hematologic Malignancy"low recruitment"
- Insufficiency; Hepatic, Postoperative"The first phase was completed"
- Lung Cancer
Active Trials (5 total)
- NCT05043857
- NCT05081531
- NCT07413523
- NCT07401615
- NCT07397585
- NCT07299357
- NCT07317245
- NCT07195942
- NCT06949254
- NCT07098247
- NCT06669312
- NCT05793489
- NCT05903261
- B-Cell Lymphoma Treatment PHASE2NCT06918912
- Acute Myeloid Leukaemia PHASE2NCT06892223
- NCT05663294
- Glioblastoma NANCT06113705
- NCT04266574
- NCT05735678
- NCT06508866